News About: Pharm. Industry
Continuous controversy over the issue of the Stillen’s clinical usefulness test… A decision will be made after the review
Through the court’s judgment towards the Dong-A ST’s ‘Stillen’, it will temporarily keep the insurance benefit; however, the ‘Clinical Usefulness Confirmation issue will still have its sore spot exposed.
The Seoul Ad...
Promotions of MSD Korea directors to foreign branches… Kwang-hyuk Lim appointed as the Animal Health Department
MSD Korea, the Korean branch of Merck, a global healthcare company, announced promotion of the Korean personnel to foreign branches and a newly appointed representative of the...
|
The top domestic pharmaceutical company in most sales without product revenue is Hanmi Pharmaceutical
Among domestic pharmaceutical companies having most sales on their own manufactured products, it turns out that the top company is Hanmai Pharmaceutical.
According to the Yakup.com’s analytic result of the current ra...
‘Disastrous’ records of listed pharmaceutical companies in business profits
Impacted by the government’s strict measure to eradicate pharmaceutical rebates, pharmaceutical companies have shown poor sales reports in the third quarter due to problems in sales activities.
According to the Yakup...
What happened during the visit of the Chinese giant pharmaceutical companies’ second-generations in Korea
It is observed that about 30 second-generations of influential pharmaceutical companies in China have visited pharmaceutical companies and hospitals in Korea to discuss investment plans in the beginning of this month....
Leadersof domestic and foreign pharmaceutical companies will gather in Seoul
Distinguished personnel, who generally manage clinical trials and research and development (R&D) of multinational pharmaceutical enterprises leading the KRW 1quadrillion global pharmaceutical market, will visit to Kor...
The significant amount of daily activity cost of multinational pharmaceutical companies
It is shown that daily activity costs of salesmen in multinational pharmaceutical companies are KRW 60,000 in maximum, and some of them pay its salesmen expenses to keep up a certain standard of appearances.
The blog...
Chong Kun Dang withdrew the twin drug of Levitra, ‘Yailla’, in the Korean pharmaceutical market
‘Yailla’, a twin drug of the impotency drug ‘Levitra’, has withdrawn in the Korean pharmaceutical market.
It has been 7 years and 10 months since the drug was approved in January 2007.
According to the Ministry of F...
SK Chemical won the second trial over the Norvatis’s dementia patch treatment
As SK Chemical won the patent war over dementia patch treatment,its position has been significantly stable in the market
The Patent Court decided to take the side of the requesting company, SK Chemical, in the appell...
The movement of multinational pharmaceutical companies to raise pharmaceutical distribution cost
It has been known that multinational pharmaceutical companies, overpowered by the aggressive action of the pharmaceutical distribution industry, are in reviewing distribution cost raise.
According to the pharmaceutic...
